Deep Track Capital, LP Keros Therapeutics, Inc. Transaction History

Deep Track Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$27.8 - $40.12 $13.7 Million - $19.7 Million	-491,028 Reduced 66.4%	248,500 $9.35 Million
Q2 2022 Aug 12, 2022	SELL	$26.03 - $67.04 $16.7 Million - $43 Million	-640,778 Reduced 46.42%	739,528 $20.4 Million
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $3.38 Million - $4.77 Million	80,306 Added 6.18%	1,380,306 $75.1 Million
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $48 Million - $81.8 Million	1,300,000 New	1,300,000 $76.1 Million

153

26.7M

47.6K

34.5K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.18B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.